Exagen (XGN) Net Margin (2018 - 2026)

Exagen (XGN) has 9 years of Net Margin data on file, last reported at 22.92% in Q1 2026.

• Quarterly Net Margin rose 129.0% year-over-year to 22.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29.49% (down 215.0% YoY) and the FY2025 annual result came in at 29.97%, down 280.0% from the prior year.
• Net Margin grew to 22.92% in Q1 2026, from 28.1% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 19.69% in Q2 2024 to a low of 219.23% in Q2 2022.
• A 5-year average of 58.82% and a median of 39.05% in 2023 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2022 — Net Margin sank 16905 bps — and 2023, when it surged 18377 bps.
• Tracing XGN's Net Margin over 5 years: stood at 112.18% in 2022, then surged by 65 bps to 39.05% in 2023, then gained by 29 bps to 27.54% in 2024, then dropped by 2 bps to 28.1% in 2025, then climbed by 18 bps to 22.92% in 2026.
• The last three Net Margin figures came in at 22.92% (Q1 2026), 28.1% (Q4 2025), and 41.1% (Q3 2025), per Business Quant data.